2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow M. Schaefer, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia Memantine, Placebo - Schizophrenia | Phase 3 | Terminated | M. Schaefer, MD | 24 | 2005-11-01 | 2019-06-27 |
| Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia Memantine, Placebos - Chronic Schizophrenia | Phase 3 | Terminated | M. Schaefer, MD | 13 | 2004-04-01 | 2019-06-27 |
Cognitive Dysfunction (2) · Schizophrenia (2)
Memantine (2)
Germany (2)